A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome
Condition(s):IBS – Irritable Bowel SyndromeLast Updated:August 30, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):IBS – Irritable Bowel SyndromeLast Updated:August 30, 2023Recruiting
Condition(s):Overweight/Obese AdultsLast Updated:November 20, 2023Not yet recruiting
Condition(s):StrokeLast Updated:July 28, 2022Active, not recruiting
Condition(s):Irritable Bowel SyndromeLast Updated:March 12, 2021Completed
Condition(s):Schistosoma MansoniLast Updated:January 22, 2010Completed
Condition(s):Healthy VolunteersLast Updated:November 6, 2017Completed
Condition(s):Bacterium; AgentLast Updated:November 6, 2015Completed
Condition(s):ObesityLast Updated:August 1, 2019Unknown status
Condition(s):HealthyLast Updated:March 25, 2019Completed
Condition(s):Low Mood; Depressive SymptomsLast Updated:November 10, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.